
A human-sized, international, and independent pharmaceutical group governed by a Foundation, committed to therapeutic progress for the benefit of patients.
We are a human-sized, international, and independent pharmaceutical group governed by a Foundation. Our unique model allows us to fully serve our vocation: 'Committed to therapeutic progress for the benefit of patients'. We are a global leader in cardiology and focus on oncology, with a global team of 22,000 people from more than 50 nationalities.
A human-sized, international, and independent pharmaceutical group governed by a Foundation, committed to therapeutic progress for the benefit of patients.